ACT 4 Children shared a post on LinkedIn:
“The ASH25 Conference in Orlando brings together the world’s leading minds in hematology – clinicians, researchers, scientists, and changemakers driving progress in patient care and treatment innovation.
Gatherings like this accelerate breakthroughs and knowledge-sharing that move us closer to conquering blood diseases, including childhood cancers such as acute lymphoblastic leukemia (ALL).
At ACT 4 Children, we share this mission and continue working to expand sustainable drug access and full-spectrum treatment support for children with cancer in low- and middle-income countries.
We’re proud to stand with global efforts advancing equity in care. Follow ACT 4 Children and American Society of Hematology to show support that can help save lives.”
More posts featuring ACT 4 Children on OncoDaily.